Scienture Holdings (SCNX) EBT (2013 - 2026)
Scienture Holdings' (SCNX) quarterly EBT came in at -$2.8 million in Q2 2026, up 58.0% year-over-year from -$1.8 million in Q2 2025, and up 17.31% quarter-over-quarter from -$3.4 million in Q1 2026.
Analysis
Scienture Holdings (SCNX) EBT (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed EBT across 14 years of filings, most recently posting -$2.8 million for Q2 2026.
- In Q2 2026, EBT rose 58.0% year-over-year to -$2.8 million; the TTM figure through Jun 2026 stood at -$16.0 million (up 11.21% YoY), while the FY2025 annual figure was -$43.5 million, down 131.68% from the prior year.
- EBT came in at -$2.8 million for Q2 2026 at Scienture Holdings, up from -$3.4 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$340474.0 in Q3 2022 to a low of -$6.7 million in Q2 2025.
- Average EBT over 5 years is -$2.6 million, with a median of -$2.2 million recorded in 2022.
- Year-over-year, EBT soared 73.84% in 2022 and plunged 667.5% in 2024.
- Over 5 years, EBT stood at -$2.8 million in 2022, then slumped by 43.67% to -$4.0 million in 2023, then soared by 59.12% to -$1.6 million in 2024, then slumped by 313.64% to -$6.7 million in 2025, then jumped by 58.0% to -$2.8 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$2.8 million in Q2 2026, -$3.4 million in Q1 2026, and -$6.7 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -455.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -64.00 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 58.37 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 70.99 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 348.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 37.10 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -66.76 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 38.54 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 2.02 Mn |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | -2.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.82 Mn |
| Mar 31, 2026 | -3.41 Mn |
| Jun 30, 2025 | -6.72 Mn |
| Mar 31, 2025 | -3.06 Mn |
| Jun 30, 2024 | -1.62 Mn |
| Mar 31, 2024 | -6.63 Mn |
| Dec 31, 2023 | -3.97 Mn |
| Sep 30, 2023 | -1.10 Mn |
| Jun 30, 2023 | -780,516.00 |
| Mar 31, 2023 | -864,284.00 |
| Dec 31, 2022 | -2.77 Mn |
| Sep 30, 2022 | -340,474.00 |
| Jun 30, 2022 | -1.11 Mn |
| Mar 31, 2022 | -969,936.00 |
| Dec 31, 2021 | -784,340.00 |
| Sep 30, 2021 | -1.30 Mn |
| Jun 30, 2021 | -2.58 Mn |
| Mar 31, 2021 | -651,519.00 |
| Dec 31, 2020 | -2.31 Mn |
| Sep 30, 2020 | 138,391.00 |